Attached files

file filename
EXCEL - IDEA: XBRL DOCUMENT - Midatech Pharma US Inc.Financial_Report.xls
10-Q - QUARTERLY REPORT - Midatech Pharma US Inc.dara_10q.htm
EX-10.3 - EMPLOYMENT AGREEMENT - Midatech Pharma US Inc.dara_ex103.htm
EX-31.2 - CERTIFICATION - Midatech Pharma US Inc.dara_ex312.htm
EX-31.1 - CERTIFICATION - Midatech Pharma US Inc.dara_ex311.htm
EX-10.2 - EMPLOYMENT AGREEMENT - Midatech Pharma US Inc.dara_ex102.htm
EXHIBIT 32
 
CERTIFICATIONS OF
PRINCIPAL EXECUTIVE OFFICER AND PRINCIPAL FINANCIAL OFFICER
PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
 
I, David J. Drutz, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Quarterly Report of DARA BioSciences, Inc. on Form 10-Q of DARA BioSciences, Inc. for the quarter ended March 31, 2013 fully complies with the requirements of Section 13(a) or 15(d) of the Exchange Act and that information contained in such Quarterly Report of DARA BioSciences, Inc. on Form 10-Q fairly presents in all material respects the financial condition and results of operations of DARA BioSciences, Inc.
 
 
  By: /s/ David J. Drutz  
  Name: David J. Drutz  
  Title: Chief Executive Officer  
  Date: May 15, 2013  
 
I, David L. Tousley, certify pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Quarterly Report of DARA BioSciences, Inc. on Form 10-Q of DARA BioSciences, Inc. for the quarter ended March 31, 2013 fully complies with the requirements of Section 13(a) or 15(d) of the Exchange Act and that information contained in such Quarterly Report of DARA BioSciences, Inc. on Form 10-Q fairly presents in all material respects the financial condition and results of operations of DARA BioSciences, Inc.
 
 
Date: May 15, 2013 By: /s/ David L. Tousley  
  Name: David L. Tousley  
  Title: Chief Financial Officer  
  Date: May 15, 2013